生物技术公司Century Therapeutics, Inc. (IPSC) 已正式向美国证券交易委员会提交招股说明书。根据文件披露,该公司计划由售股股东根据市场情况,在未来不定期地发售及转售最多1.761亿股普通股。此次股份发售的具体条款,包括发售价格和时间,将根据市场状况和公司需求而定。
生物技术公司Century Therapeutics, Inc. (IPSC) 已正式向美国证券交易委员会提交招股说明书。根据文件披露,该公司计划由售股股东根据市场情况,在未来不定期地发售及转售最多1.761亿股普通股。此次股份发售的具体条款,包括发售价格和时间,将根据市场状况和公司需求而定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.